What is StudyMetrix Research?
StudyMetrix Research operates as an independent research clinic situated in the Greater St. Louis/St. Charles region of Missouri. The organization specializes in conducting Phase II-IV clinical trials, focusing on the advancement of medical research and the enhancement of patient care through the provision of innovative treatments for a spectrum of medical conditions. Central to their mission is a commitment to volunteer-centered care, offering personalized support to participants throughout their involvement in clinical trial processes. StudyMetrix Research endeavors to improve the efficiency of drug development pipelines and contribute to the discovery of life-changing medical breakthroughs.
How much funding has StudyMetrix Research raised?
StudyMetrix Research has raised a total of $110K across 1 funding round:
Debt
$110K
Debt (2021): $110K with participation from PPP
Key Investors in StudyMetrix Research
PPP
Public-Private Partnership
What's next for StudyMetrix Research?
With the recent strategic investment, StudyMetrix Research is poised for accelerated expansion and enhanced operational capabilities. This significant capital infusion is expected to fuel further development in their clinical trial methodologies, potentially broadening their therapeutic areas of focus and increasing their capacity to serve more patients. The company's late-stage funding context suggests a strategic push towards market penetration and solidifying its position as a key player in medical research innovation. Future initiatives will likely involve expanding research infrastructure, forging new partnerships with pharmaceutical companies, and potentially exploring new geographic markets to broaden their reach and impact on global health.
See full StudyMetrix Research company page
